REGENXBIO

REGENXBIO is a biotechnology company that develops gene therapy treatments to address serious diseases. They use a proprietary technology called NAV Technology, which involves delivering healthy copies of genes directly into a patient's cells using specialized viral vectors. This approach aims to provide long-lasting or permanent cures for conditions such as vision loss, genetic disorders, and neurodegenerative diseases. By harnessing the body's own cells to produce needed proteins, REGENXBIO's therapies have the potential to significantly improve patients' health and quality of life.